Systemic scleroderma: Multicenter trial of 1 year of treatment with recombinant interferon gamma

Archives of Dermatology

Volumn 133, Issue 5, 1997, Pages 609-613

  Hunzelmann, Nicolas ^a   Anders, Sabine ^a   Fierlbeck, Gerhard ^b   Hein, Rüdiger ^c   Herrmann, Konrad ^d   Albrecht, Manuela ^d   Bell, Sabine ^e   Thur, Jochen ^a   Muche, Rainer ^f   Adelmann Grill, Bernhard ^g   Wehner Caroli, Jörg ^b   Gaus, Wilhelm ^f   Krieg, Thomas ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

^d UNIVERSITY OF LEIPZIG   (Germany)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^f UNIVERSITY OF ULM   (Germany)

^g MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; MESSENGER RNA; RECOMBINANT GAMMA INTERFERON;

ADULT; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONNECTIVE TISSUE DISEASE; DIARRHEA; FATIGUE; FEVER; GENE EXPRESSION; HEADACHE; HUMAN; HUMAN TISSUE; MULTICENTER STUDY; MYOSITIS; NAUSEA; PRIORITY JOURNAL; SKIN BIOPSY; SKIN ULCER; SUBCUTANEOUS DRUG ADMINISTRATION; SYSTEMIC SCLEROSIS; TACHYCARDIA; WEIGHT GAIN;

EID: 0030992808     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.133.5.609     Document Type: Article

References (28)

1. Jablonska S. Scleroderma and Pseudoscleroderma. 2nd ed. Warsaw, Poland: Polish Medical Publishers; 1975.
2. Krieg T, Meurer M. Systemic scleroderma: clinical and pathophysiological aspects. J Am Acad Dermatol. 1988;18:457-481.
3. Le Roy EC. Increased collagen synthesis by scleroderma fibroblasts in vitro. J Clin Invest. 1974;54:880-889.
4. Uitto J, Bauer E, Eisen A. Increased biosynthesis of triple helical type I and type III procollagens associated with unaltered expression of collagenase by skin fibroblasts in culture. J Clin Invest. 1979;64:921-932.
5. Scharfetter K, Lankat-Buttgereit B, Krieg T. Localization of collagen mRNA in normal and scleroderma skin by in situ hybridization. Eur J Clin Invest. 1988;18:9-17.
6. Roberts AB, Sporn MB, Assoian RK, et al. Transforming growth factor-β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A. 1986;83:4167-4171.
7. Kulozik M, Hogg A, Lankat-Buttgereit B, Krieg T. Co-localization of transforming growth factor-2 with alpha 1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis. J Clin Invest. 1990;86:917-922.
8. Jimenez SA, Freundlich B, Rosenbloom J. Selective inhibition of human diploid fibroblast collagen synthesis by interferons. J Clin Invest 1985;76:836-848.
9. Heckmann M, Aumailley M, Hatamochi A, Chu ML, Timpl R, Krieg T. Down-regulation of a3(VI) chain expression by interferon-γ decreases synthesis and deposition of collagen VI. Eur J Biochem. 1989;182:719-726.
10. Duncan MR, Bermann B. γ-interferon is the lymphokine and α-interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation, J Exp Med. 1985;162:516-527.
11. Kahari VM, Heino J, Vuorio T, Vuorio E. (nterferon-α and interferon-γ reduce excessive collagen synthesis and procollagen mRNA levels of scleroderma fibroblasts in culture. Biochem Biophys Acta. 1988;968:45-50.
12. Adelmann-Grill BC, Hein R, Wach F, Krieg T, Inhibition of fibroblast chemotaxis by recombinant human interferon alpha and interferon gamma. J Cell Physiol. 1988;130:280-285.
13. Majewski S, Hunzelmann N, Schirren CG, Mauch C, Aumailley M, Krieg T. Increased adhesion of fibroblasts from patients with scleroderma to extracellular matrix components: in vitro modulation by interferon-γ but not TGf-β. J Invest Dermatol. 1992;98:86-91.
14. Varga JA, Olsen J, Herhal J, Constantine G, Rosenbloom, Jimenez S. Interferon-γ reverses the stimulation of collagen but not fibronectin gene expression by transforming growth factor-β in normal human fibroblasts. Eur J Clin Invest. 1990;20:1489-1495.
15. Garnstein RD, Murphy GF, Margolis RJ, Byrne MH, Amento E. Gamma-interferon inhibits collagen synthesis in vivo in the mouse. J Clin Invest. 1987;79:1254-1258.
16. Kahan A, Amor S, Menkes CJ, Strauch G. Recombinant interferon-γ in the treatment of systemic sclerosis. Am J Med. 1989;87:273-277.
17. Freundlich B, Jimenez S, Steen V, Medsger T, Skolnicki M, Jaffee H. Treatment of systemic sclerosis with recombinant IFN-γ. Arthritis Rheum. 1992;35:1134-1142.
18. Hein R, Behr J, Hündgen M, et al. Treatment of systemic sclerosis with γ-interferon. Br J Dermatol. 1992;126:496-501.
19. Arbeitsgruppe Sklerodermie der Arbeitsgemeinschaft Dermatologische Forschung (ADF) Klinik der progressiven systemischen Sklerodermie (PSS). Hautarzt. 1986;37:320-324.
20. Kanalen MB, Sultany GL, Smith EY, et al. A modified scleroderma skin scoring method. Clin Exp Rheumatol. 1986;4:367-369.
21. Herrmann K, Heckmann M, Kulozik M, Haustein UF, Krieg T. Steady state mRNA levels of collagens I, III, fibronectin, and collagenase in skin biopsies of systemic sclerosis patients. J Invest Dermatol. 1991;97:219-222.
22. Chu ML, Myers JC, Bernard MP, Ding DF, Ramirez F. Cloning and characterization of five overlapping cDNAs specific for the human α1 (I) collagen chain. Nucleic Acids Res. 1982;10:5925-5934.
23. Thur J, Nischt R, Krieg T, Hunzelmann N. Quantitative analysis of α1 type I collagen expression by competitive polymerase chain reaction. Matrix Biol. 1996;15:49-52.
24. Le Roy EC, Smith EA, Kahaleh MB, Trojanowska M, Silver RM. A strategy for determining the pathogenesis of systemic sclerosis: is TGF-β the answer? Arthritis Rheum. 1989;32:817-825.
25. Rudnicka L, Varga J, Christiane A, Iozzo RV, Jimenez SA, Uitto T. Elevated expression of type VII collagen in the skin of patients with systemic sclerosis. J Clin Invest. 1994;93:1709-1715.
26. Rombaldi A, Young DC, Herman F, Canistra SA, Griffin JD. Interferon gamma induced expression of II-2 receptor gene in human monocytes. Eur J Immunol. 1987;17:153-156.
27. Czaja MJ, Weiner FR, Eghbali M, Giambrone MA, Eghbali M, Zern M. Differential effects of γ-interferon on collagen and fibronectin gene expression. J Biol Chem. 1987;262:13348-13351.
28. Hunzelmann N, Roux M, Goebels N, Majewski S, Krieg T, Interferon-gamma and tumor necrosis factor a synergistically induce ICAM-1 but not LFA-3 in human dermal fibroblasts. Arch Dermatol Res. 1992;284:67.